Indian pharma giant Dr. Reddy’s Laboratories Ltd. says Health Canada has rejected its application to make generic semaglutide, a setback for what was poised to be one of the first generic competitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback